We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.41%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$67.1B
AUM Growth
-$1.4B
(-2%)
Cap. Flow
+$2.19B
Cap. Flow
% of AUM
3.26%
Top 10 Holdings %
Top 10 Hldgs %
22.03%
Holding
3,122
New
29
Increased
2,768
Reduced
217
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$146M |
| 2 |
Apple
AAPL
|
+$75.7M |
| 3 |
Tesla
TSLA
|
+$70.4M |
| 4 |
Amazon
AMZN
|
+$65M |
| 5 |
Procter & Gamble
PG
|
+$55.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACC
American Campus Communities, Inc.
ACC
|
+$27.2M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$21.1M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$19.2M |
| 4 |
COHR
Coherent Inc
COHR
|
+$18.8M |
| 5 |
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 14.42% |
| 3 | Financials | 13.62% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Theravance Biopharma
TBPH
$877M
| $818K | ﹤0.01% |
80,628
+5,748
| +8% | +$53.9K |
|
|
ACRE
2252
Ares Commercial Real Estate
ACRE
$270M
| $816K | ﹤0.01% |
78,091
+13,802
| +21% | +$179K |
|
|
EGRX
2253
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $815K | ﹤0.01% |
30,851
+69
| +0.2% | +$2.53K |
|
2254
Select Water Solutions
WTTR
$2.61B
| $814K | ﹤0.01% |
116,797
+6,063
| +5% | +$42.1K |
|
|
FSP
2255
Franklin Street Properties
FSP
$46.8M
| $812K | ﹤0.01% |
308,752
+2,193
| +0.7% | +$7.23K |
|
2256
Gorman-Rupp
GRC
$2.21B
| $811K | ﹤0.01% |
34,069
+2,058
| +6% | +$55.8K |
|
2257
Universal Insurance Holdings
UVE
$1.23B
| $811K | ﹤0.01% |
82,314
+2,397
| +3% | +$28.7K |
|
2258
Sterling Infrastructure
STRL
$16.7B
| $810K | ﹤0.01% |
37,716
+2,805
| +8% | +$67.4K |
|
|
RDFN
2259
DELISTED
Redfin
RDFN
| $809K | ﹤0.01% |
138,547
+15,571
| +13% | +$138K |
|
2260
Anterix
ATEX
$1.94B
| $804K | ﹤0.01% |
22,495
+6,553
| +41% | +$272K |
|
2261
N-able
NABL
$940M
| $804K | ﹤0.01% |
87,067
+6,349
| +8% | +$61.8K |
|
2262
Pennant Group
PNTG
$1.36B
| $804K | ﹤0.01% |
77,211
+4,521
| +6% | +$64.6K |
|
2263
IDEAYA Biosciences
IDYA
$3.56B
| $801K | ﹤0.01% |
53,678
+3,671
| +7% | +$47.7K |
|
2264
First Community Bankshares
FCBC
$911M
| $800K | ﹤0.01% |
24,966
+1,372
| +6% | +$43.4K |
|
2265
Health Catalyst
HCAT
$128M
| $797K | ﹤0.01% |
82,192
+5,330
| +7% | +$70.6K |
|
|
DENN
2266
DELISTED
Denny's
DENN
| $796K | ﹤0.01% |
84,561
+4,559
| +6% | +$43.7K |
|
2267
Nordic American Tanker
NAT
$1.37B
| $795K | ﹤0.01% |
297,829
+30,396
| +11% | +$80.7K |
|
2268
TFS Financial
TFSL
$4.93B
| $794K | ﹤0.01% |
61,108
+7,284
| +14% | +$103K |
|
|
GOLD
2269
Gold.com Inc
GOLD
$1.26B
| $790K | ﹤0.01% |
27,833
+1,572
| +6% | +$47.8K |
|
2270
Mercer International
MERC
$39.8M
| $789K | ﹤0.01% |
64,144
-1,102
| -2% | -$16.3K |
|
2271
Stagwell
STGW
$2.24B
| $789K | ﹤0.01% |
113,504
+6,820
| +6% | +$44K |
|
2272
CRA International
CRAI
$1.06B
| $788K | ﹤0.01% |
8,885
+575
| +7% | +$52.8K |
|
2273
Douglas Dynamics
PLOW
$1.02B
| $788K | ﹤0.01% |
28,111
+1,918
| +7% | +$58.4K |
|
|
ALX
2274
Alexander's
ALX
$1.41B
| $785K | ﹤0.01% |
3,757
+192
| +5% | +$45.4K |
|
2275
EVgo
EVGO
$229M
| $785K | ﹤0.01% |
99,225
+5,804
| +6% | +$50.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, RhumbLine Advisers held 3,122 positions worth $67.1B, down 2% from $68.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2.19B of net new capital in Q3 2022, opening 29 new positions and adding to 2,768 existing holdings. Its largest new stake was Enhabit: 136,327 shares worth $1.91M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $21.1M trimmed.
- RhumbLine Advisers's largest Q3 2022 buy was Enhabit: 136,327 shares worth $1.91M.
- RhumbLine Advisers added most to Microsoft in Q3 2022, an estimated $146M increase.
- RhumbLine Advisers's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $21.1M.
- RhumbLine Advisers fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $27.2M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $67.1B portfolio in Q3 2022.
- RhumbLine Advisers opened 29 new positions and closed 40 in Q3 2022.
- RhumbLine Advisers's portfolio value fell 2% quarter-over-quarter to $67.1B.
Based on RhumbLine Advisers's 13F filing for Q3 2022, filed 10 Nov 2022.